3Zong ZY, LU XJ, Gao YY. Metallo-β-lactamases of non-fermenting Gram-negative bacteria. Rev Med Microbiol, 2003, 14 : 79-94.
4Livermore DM. The impact of carbapenemases on antimicrobial development and therapy. Curr Opin Investig Drugs, 2002, 3:218-224.
5Senda K, Arakawa Y, Nakashima K, et al. Multifocal outbreaks of metallo-beta-lactamase producing Psendomonas aeruginosa resistant to broad-spectrum beta-lactams, including carbapenems. Antimicreb Agents Chemother, 1996, 40 : 349-353.
6Hirakata Y, Izumikawa K, Yamaguchi T. Rapid detection and evaluation of clinical characteristics of emerging multiple-drug-resistant gram-negative reds carrying the metallo-beta-lactamase gene blaIMP. Antimicreb Agents Chemother, 1998, 42: 2006-2011.
7Migliavacca R, Docquier JD, Mugnaioli C, et al. Simple microdilution test for detection of metallo-beta-lactamase production in Pseudomonas aeruginosa. J Clin Microbiol, 2002, 40: 4388-4390.
8Levin AS. Multiresistant Acinetobacter infections: a role for sulbactam combinations in overcoming an emerging worldwide problem. Clin Microbiol Infect, 2002, 8 : 144-153.
9Levin AS, Levy CE, Manrique AE, et al. Severe nosocomial infections with imipenem-resistant Acinetobacter baumannii treated with ampicillin/sulbactam. Int J Antimicreb Agents, 2003, 21:58-62.
10LEVIN A S. Multiresistant acinetobacter infections: a role for sulbactam combinations in overcoming an emerging worldwideproblem [J]. Clin Microbiol Infect, 2002, 8(3): 144 - 153.
